Psychedelics and cognitive liberty: Reimagining drug policy through the prism of human rights

International Journal of Drug Policy

Volumn 29, Issue , 2016, Pages 80-87

  Walsh, Charlotte ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cognitive liberty; Drug policy; Human rights; Psychedelics

Indexed keywords

PSYCHEDELIC AGENT;

ARTICLE; COGNITIVE LIBERTY; COURT; DRUG LEGISLATION; DRUG PROGRAM; GOVERNMENT REGULATION; HARM REDUCTION; HEALTH CARE POLICY; HUMAN; HUMAN RIGHTS; INTELLECTUAL FREEDOM; JURISPRUDENCE; PRIORITY JOURNAL; RELIGION; COGNITION; FREEDOM;

COGNITION; FREEDOM; HALLUCINOGENS; HEALTH POLICY; HUMAN RIGHTS; HUMANS;

EID: 84975770102     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.12.025     Document Type: Article

References (37)

1. Armentano P. Emerging clinical applications for cannabis and cannabinoids: A review of the recent scientific literature 2014, NORML, Washington, DC. 6th ed.
2. Bey H. Against legalisation. Journal of Cognitive Liberties 1999/2000, 1(1):34-38.
3. Boire R.G. On cognitive liberty (part 1). Journal of Cognitive Liberties 1999/2000, 1(1):7-13.
4. Bone M., Seddon T. Human rights, public health and medicinal cannabis use. Critical Public Health 2015, 26(1):1-11.
5. Carhart-Harris R., Nutt D. Experienced drug users assess the harms and benefits of drugs: A web-based survey. Journal of Psychoactive Drugs 2013, 45(4):322-328.
6. EMCDDA The Internet and drug markets 2015, EMCDDA, Lisbon.
7. Gibson M. Rastafari and cannabis: Framing a criminal law exemption. Ecclesiastical Law Journal 2010, 12(3):324-344.
8. Grinspoon L., Bakalar J.B. Psychedelic drugs reconsidered 1997, Lindesmith Centre, New York.
9. Grof S. LSD psychotherapy 2008, MAPS, Santa Cruz.
10. Hari J. Chasing the scream: The first and last days of the war on drugs 2015, Bloomsbury, London.
11. Holland J. The pot book 2010, Park Street Press, Vermont.
12. Husak D. Drugs and rights 1992, Cambridge University Press, Cambridge.
13. Jay M. High society: Mind-altering drugs in history and culture 2010, Thames and Hudson, London.
14. Labate B.C., Cavnar C. Ayahuasca shamanism in the Amazon and beyond 2014, Oxford University Press, Oxford.
15. Labate B.C., Cavnar C. Prohibition, religious freedom and human rights: Regulating traditional drug use 2014, Springer-Verlag, Berlin.
16. Labate B.C., Cavnar C. The therapeutic use of ayahuasca 2014, Springer-Verlag, Berlin.
17. MAPS Psychedelics in Psychology and Psychiatry 2013, 23:1.
18. McKenna T. Psychedelic society. Entheogens and the future of religion 1997, Council on Spiritual Practices, San Francisco. R. Forte (Ed.).
19. Mill J.S. On liberty 1982, Penguin English Library, London.
20. Nutt D.J., King L.A., Phillips D. Drug harms in the UK: A multicriteria decision analysis. The Lancet 2010, 376(9752):1558-1565.
21. Possamai A. Sociology of religion for generations X and Y 2009, Equinox Publishing Ltd., London.
22. Power M. Drugs 2.0: The web revolution that's changing how the world gets high 2013, Portobello Books Ltd., London.
23. Harm reduction: Evidence, impacts and challenges 2010, EMCDDA, Lisbon. T. Rhodes, D. Hedrich (Eds.).
24. Richards D. Sex, drugs, death and the law: An essay on over-criminalisation 1986, Rowman and Littlefield, Lanham.
25. Roberts M. Making drug policy together: Reflections on evidence, engagement and participation. International Journal of Drug Policy 2014, 25:952-956.
26. Roberts T. Academic and religious freedom in the study of the mind. Entheogens and the future of religion 1997, Council on Spiritual Practices, San Francisco. R. Forte (Ed.).
27. Ruiz-Sierra J. Is it time for a cognitive liberty social movement?. Journal of Cognitive Liberties 2003, 4(2):53-62.
28. Seddon T. Drug policy and global regulatory capitalism: The case of New Psychoactive Substances (NPS). International Journal of Drug Policy 2014, 25:1019-1024.
29. Szasz T. Our right to drugs: The case for a free market 1996, Syracuse University Press, New York.
30. Sznitman S.R., Zolotov Y. Cannabis for therapeutic purposes and public health and safety: A systematic and critical review. International Journal of Drug Policy 2015, 26:20-29.
31. Tagliazucchi E., Carhart-Harris R., Leech R., Nutt D., Chialvo D.R. Enhanced repertoire of brain dynamical states during the psychedelic experience. Human Brain Mapping 2014, 35(11):5442-5456.
32. Thoumi F.E. Marijuana in the United States and the international drug control regime: Why what is promoted abroad is not applied at home. Crime, Law, Social Change 2014, 61:273-285.
33. Transform Debating drugs: How to make the case for legal regulation 2014, Bristol: Transform.
34. Van Hout M.C., Bingham T. Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. International Journal of Drug Policy 2014, 25:183-189.
35. Walsh C. Drugs and human rights: Private palliatives, sacramental freedoms and cognitive liberty. International Journal of Human Rights 2010, 14(3):425-441.
36. Walsh C. Drugs, the internet, and change. Journal of Psychoactive Drugs 2011, 43(1):55-63.
37. Walsh C. Plant psychedelics in the English court: Legal uncertainty, guinea pigs and dog law. The psychedelic policy quagmire: Health, law, freedom and society 2015, Praeger Publishers, Conneticut. J.H. Ellens, T. Roberts (Eds.).